Cladribine in Patients With Mantle Cell Lymphoma
Study Information
Alliance Study ID: NCCTG-958053
NCT Study ID (ClinicalTrials.gov): NCT00002879
Disease or Cancer Type: Lymphoma
Alliance Study Chair: David J. Inwards, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effects of cladribine in previously treated or untreated patients with mantle cell lymphoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information